Skip to main content
. 2021 Aug 28;27(32):5341–5350. doi: 10.3748/wjg.v27.i32.5341

Table 1.

Summary of studies on differential diagnosis of hepatocellular carcinoma

Ref.
Aim of the study
Modality
Patients
Method
AUC of the final model
Nie et al[7] Differentiation between HCC and HCA CT 131 ML T: 0.96, V: 0.94
Nie et al[8] Differentiation between HCC and FNH CT 156 ML T: 0.979, V: 0.917
Mokrane et al[9] Differentiation between HCC and non-HCC nodules CT 178 ML T: 0.70, V: 0.66
Ponnoprat et al[10] Differentiation between HCC and ICC CT 257 ML NA
Shi et al[11] Differentiation of HCC from other FLLs CT 342 DL 0.925
Yasaka et al[12] Liver mass classification CT 560 DL 0.92
Cao et al[13] FLL classification CT 375 DL V: 0.88-0.99
Jiang et al[14] Comparing the diagnostic accuracies of EASL (v2018), LI-RADS criteria, and radiomics models for HCC MRI 211 ML T: 0.861, V: 0.810
Zhen et al[15] Classification of liver tumors MRI 1411 DL 0.963-0.998
Liu et al[16] Differentiation of cHCC-CC from CC and HCC MRI 85 ML 0.77
Huang et al[17] Diagnosis of DPHCC MRI 100 ML 0.784
Jian et al[18] Characterization of HCC MRI 112 DL NA
Wu et al[19] Classification of HCC and hepatic hemangioma MRI 369 ML T: 0.86, V: 0.89

T: Training cohort; V: Validation cohort; NA: Not available; AUC: The area under the receiver operating characteristic curve; ML: Machine learning; DL: Deep learning; HCC: Hepatocellular carcinoma; HCA: Hepatocellular adenoma; FNH: Focal nodular hyperplasia; ICC: Intrahepatic cholangiocarcinoma; cHCC-CC: Combined hepatocellular cholangiocarcinoma; CC: Cholangiocarcinoma; DPHCC: Dual-phenotype hepatocellular carcinoma; FLL: Focal liver lesion.